Our platforms are catalyzing drug discoveryfor all major diseases


ELVIS&ROSALYND

We are therapeutic area agnostic, and are currently applying our platforms to novel hit discovery, hit-to-lead, and lead optimization campaigns in the following disease areas.


Neuroscience Chronic pain
Infectious Disease covid-19, non-tuberculosis mycobacterium (NTM)
Immunology Psoriasis, Multiple Sclerosis
Oncology Blood Cancers, Solid tumors
Aging eye disorders, Osteoarthritis
Metabolism Type I & Type II Diabetes, Hypercholesterolemia